(Q81858301)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

botulinum toxin type A

1 reference

P Roggenkämper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

W H Jost

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

K Bihari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

G Comes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

S Grafe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

NT 201 Blepharospasm Study Team

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

15 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

303-312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00702-005-0323-3

12 January 2020

exact match

0 references

cites work

Pathophysiology of dystonia: a neuronal model

1 reference

12 December 2020

Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences

1 reference

12 December 2020

Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force

1 reference

12 December 2020

Blepharospasm: demographic and clinical survey of 250 patients

1 reference

12 December 2020

Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis.

1 reference

12 December 2020

Development of resistance to botulinum toxin type A in patients with torticollis

1 reference

12 December 2020

Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Blepharospasm: a review of 264 patients

1 reference

12 December 2020

Botulinum A toxin injection as a treatment for blepharospasm

1 reference

12 December 2020

Abnormal eye movements in blepharospasm and involuntary levator palpebrae inhibition. Clinical and pathophysiological considerations.

1 reference

12 December 2020

Clinical presentation and management of antibody-induced failure of botulinum toxin therapy

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence of focal dystonias in the western area of Tottori Prefecture in Japan

1 reference

12 December 2020

Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm

1 reference

12 December 2020

Botulinum toxin type A therapy for blepharospasm

1 reference

12 December 2020

Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers

1 reference

12 December 2020

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

1 reference

12 December 2020

Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia

1 reference

12 December 2020

Treatment choices of 119 patients with hemifacial spasm over 11 years

1 reference

12 December 2020

Management of spasticity associated pain with botulinum toxin A.

1 reference

12 December 2020

Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy.

1 reference

12 December 2020

Pretarsal application of botulinum toxin for treatment of blepharospasm

1 reference

12 December 2020

Treatment of blepharospasm with high dose brow injection of botulinum toxin

1 reference

12 December 2020

Blepharospasm: past, present, and future

1 reference

12 December 2020

Botulinum toxin therapy, immunologic resistance, and problems with available materials

1 reference

12 December 2020

Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.

1 reference

12 December 2020

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study

1 reference

12 December 2020

10.1007/S00702-005-0323-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959841%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference